Vidrine, Jennifer I.
Fennell, Bethany Shorey
Simmons, Vani N.
Sutton, Steven K.
Jones, Sarah R.
Woodward, Honor W.
Hoogland, Charles E.
Vidrine, Damon J.
Funding for this research was provided by:
James and Esther King Florida Biomedical Research Program (22K02, Principal Investigator JIV)
NCI Cancer Center Support Grant (P30CA076292, awarded to Moffitt Cancer Center, P30CA076292, awarded to Moffitt Cancer Center, P30CA076292, awarded to Moffitt Cancer Center, P30CA076292, awarded to Moffitt Cancer Center, P30CA076292, awarded to Moffitt Cancer Center, P30CA076292, awarded to Moffitt Cancer Center, P30CA076292, awarded to Moffitt Cancer Center, P30CA076292, awarded to Moffitt Cancer Center)
National Institutes of Health Training Grant in Behavioral Oncology (T32CA090314-18, MPIs: Vadaparampil, Simmons)
Article History
Received: 30 May 2023
Accepted: 25 June 2023
First Online: 4 July 2023
Declarations
:
: The authors declare that they have no competing interests.
: This study protocol was reviewed and approved by the Institutional Review Board at Moffitt Cancer Center in Tampa, FL (USA) on April 22, 2022. IRB# 21885. Informed consent will be obtained from potential participants. All methods will be carried out in accordance with relevant guidelines and regulations.
: Not applicable because we will not collect or publish videos of participants in this study. Additionally, no details on individuals are reported within the manuscript.